NCT01905254

Brief Summary

Recent, research has focused on the evaluation of non-invasive methods for the assessment of liver fibrosis in patients with chronic liver disease. Among these methods, transient elastography is the most promising. The method has been investigated mainly in patients with viral hepatitis. Several studies have shown, that the optimal cut-off value of TE for detection of liver cirrhosis by transient elastography is highly dependent on the aetiology of the underlying liver disease. Only a few studies have evaluated the value of transient elastography for patients with autoimmune liver disease and here primarily patients with PBC and PSC. For patients with autoimmune hepatitis the data is limited. We prospectively investigated the diagnostic accuracy of TE in autoimmune hepatitis compared to liver histology with and without inclusion of the macroscopic appearance using mini-laparoscopy

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2007

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2007

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2010

Completed
2.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2013

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

July 1, 2013

Completed
22 days until next milestone

First Posted

Study publicly available on registry

July 23, 2013

Completed
1.8 years until next milestone

Results Posted

Study results publicly available

May 6, 2015

Completed
Last Updated

May 6, 2015

Status Verified

May 1, 2015

Enrollment Period

3 years

First QC Date

July 1, 2013

Results QC Date

December 7, 2014

Last Update Submit

May 4, 2015

Conditions

Keywords

Transient elastographymini-laparoscopyliver biopsyliver cirrhosisautoimmune hepatitis

Outcome Measures

Primary Outcomes (1)

  • Sensitivity and Specifity of Transient Elastography in Detection of Liver Cirrhosis

    The aim of the current study was to assess the diagnostic accuracy (Sens., Spec.) of transient elastography for the determination of cirrhosis in patients with autoimmune hepatitis. TE was compared to the diagnosis of cirrhosis made on histology yielded by laparoscopic guided liver biopsy.

    Transient Elastography compared to liver histology

Study Arms (1)

Transient elastography and liver biopsy

OTHER

All patients with Autoimmune hepatitis (AIH) were investigated with Transient Elastography before liver biopsy

Device: Transient elastography (TE)Other: Liver biopsy

Interventions

TE and minilaparoscopic guided liver biopsy were performed by physicians blinded to the results the other within a period of less than 3 months.

Transient elastography and liver biopsy

Minilaparoscopic guided liver biopsy was performed within a period of 3 months of Transient Elastography

Transient elastography and liver biopsy

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Confirmed diagnosis of AIH based on the diagnostic criteria revised by the International Autoimmune Hepatitis Group 2008 (20):
  • liver related autoantibodies,
  • hypergammaglobulinaemia,
  • typical histological findings and
  • absence of viral markers.

You may not qualify if:

  • morbid obesity (BMI \> 40),
  • ascites, ileus or subileus,
  • peritonitis,
  • pregnancy,
  • extrahepatic cholestasis and
  • a severe inflammatory flare of AIH.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dept of Gastroenterology and Hepatology, University Medical Center Hamburg Eppendorf

Hamburg, Hamburg, 20246, Germany

Location

MeSH Terms

Conditions

Liver CirrhosisHepatitis, Autoimmune

Condition Hierarchy (Ancestors)

Liver DiseasesDigestive System DiseasesFibrosisPathologic ProcessesPathological Conditions, Signs and SymptomsHepatitis, ChronicHepatitisAutoimmune DiseasesImmune System Diseases

Results Point of Contact

Title
PD Dr. Ulrike Denzer
Organization
Universitiy Clinic Hamburg eppendorf

Study Officials

  • Ulrike W Denzer, MD

    Universitätsklinikum Hamburg-Eppendorf

    PRINCIPAL INVESTIGATOR
  • Ansgar W Lohse, MD

    Universitätsklinikum Hamburg-Eppendorf

    STUDY CHAIR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Attending physician

Study Record Dates

First Submitted

July 1, 2013

First Posted

July 23, 2013

Study Start

August 1, 2007

Primary Completion

August 1, 2010

Study Completion

January 1, 2013

Last Updated

May 6, 2015

Results First Posted

May 6, 2015

Record last verified: 2015-05

Locations